Acromegaly and cardiovascular risk - In light of 30 cases

Abstract

Acromegaly is a rare disease with an estimated incidence of 40 to 100 cases per million population. It is due to a hypersecretion of growth hormone (GH), most often by a pituitary somatotropic adenoma, sometimes by a mixed adenoma with GH and very rarely by an ectopic secretion of GHRH [1].It remains a serious disease, reducing life expectancy by an average of 10 years due to its cardiovascular and metabolic repercussions, which is why it is so important to systematically screen all risk factors and to take them into account charge.The main objective of our study is to analyze the different cardiovascular risk factors during acromegaly and their combination in the same patient.